Severe diffuse adenovirus 7a pneumonia in a child with combined immunodeficiency: Possible therapeutic effect of human immune serum globulin containing specific neutralizing antibody

Ron Dagan, Robert H. Schwartz, Richard A. Insel, Marilyn A. Menegus

Research output: Contribution to journalArticlepeer-review

57 Scopus citations

Abstract

Adenoviruses account for 4 to 10% of childhood pneumonia, but severe disease rarely occurs in im-munocompetent individuals.1 Recent evidence suggests that immunocompromised hosts may have more severe adenovirus disease with fulminant, rapidly progressive and often fatal illness. Such illness has been seen in patients immunocompromised by malignancy, steroid therapy and immunosuppressive therapy, as well as in patients with primary immunodeficiency disease.1-3 The precise role that antibody-and cell-mediated immune mechanisms play in the host resistance to adenovirus infection has not been defined. Evidence does exist that the lack of neutralizing an-tibody and the inability to produce adenovirus type-specific antibody are associated with more severe and fatal disease.2 The possibility that passively acquired antibody may ameliorate adenoviral disease in the immunocompromised host is raised by the followingcase.

Original languageEnglish
Pages (from-to)246-251
Number of pages6
JournalPediatric Infectious Disease
Volume3
Issue number3
StatePublished - 1 Jan 1984
Externally publishedYes

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Microbiology (medical)

Fingerprint

Dive into the research topics of 'Severe diffuse adenovirus 7a pneumonia in a child with combined immunodeficiency: Possible therapeutic effect of human immune serum globulin containing specific neutralizing antibody'. Together they form a unique fingerprint.

Cite this